News

Keep up with our progress

Stay up to date with the latest Paratus news as we discover and develop groundbreaking therapeutics.

PS-1001, a Novel Pan-Inflammasome Inhibitor Targeting the Adaptor Protein ASC: A Platform Candidate for Inflammasome-Driven Inflammatory Diseases

Paratus Sciences Announces Updates to its Board of Directors

Paratus Sciences Presents Preclinical and Translational Data on PS-1001, a First-in-Class Pan-Inflammasome Inhibitor, at FOCIS 2026

Validating the “Bat Engine” for Target Discovery: PS-1001, a First-in-Class Pan-Inflammasome Inhibitor Inspired by Evolutionary Biology

Paratus Appoints Alicia Secor as President and Chief Executive Officer; Expands Leadership Team to Support Next Phase of Growth

PS-1001: A novel Pan-Inflammasome Inhibitor targeting ASC for the treatment of Hidradenitis Suppurativa

Scroll to Top